Related Experiment Video
Updated: May 1, 2026
06:04
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
1.7K
Postprandial lipemia as a cardiometabolic risk factor.
Angela Pirillo1, Giuseppe Danilo Norata, Alberico Luigi Catapano
1Center for the Study of Atherosclerosis , Ospedale Bassini, Cinisello Balsamo , Italy.
Current Medical Research and Opinion
|March 29, 2014
Summary
High triglyceride (TG) levels after meals are linked to cardiovascular disease risk, even with normal fasting TG. Managing postprandial lipemia through lifestyle or medication may reduce heart disease risk.
Area of Science:
- Cardiovascular Science
- Metabolic Health
- Lipid Metabolism
Background:
- Elevated fasting triglycerides (TG) are a known cardiovascular disease (CVD) risk factor.
- Western lifestyles involve prolonged postprandial states with fluctuating triglyceride-rich lipoproteins (TRLs).
- Impaired postprandial lipoprotein metabolism is increasingly implicated in coronary artery disease (CAD) pathogenesis.
Purpose of the Study:
- To highlight the significance of postprandial lipemia in cardiovascular risk.
- To explore factors influencing postprandial lipid metabolism.
- To suggest therapeutic strategies targeting postprandial TG levels.
Main Methods:
- Review of current scientific literature on postprandial lipid metabolism.
- Analysis of factors affecting postprandial triglyceride levels.
- Examination of the association between postprandial hypertriglyceridemia and cardiovascular conditions.
Main Results:
- Postprandial hypertriglyceridemia is prevalent in Western populations due to lifestyle and dietary factors.
- Conditions like type 2 diabetes, insulin resistance, and obesity are associated with higher postprandial TG.
- This association persists even in individuals with normal fasting TG levels.
Conclusions:
- Postprandial lipid metabolism plays a critical role in cardiovascular health.
- Lifestyle modifications and pharmacological interventions targeting postprandial TG can mitigate cardiovascular risk.
- Further research into managing postprandial lipemia is warranted for effective CVD prevention.
Related Concept Videos
01:24Overview of Lipid Metabolism
7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:29Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
01:29Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25